{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/js\/js_itu2PgFdrjV-docKmLK8Jn5oXe_05RgvQh73eOhI_mE.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js?nzn4sd\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js?nzn4sd\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/js\/js_I8yX6RYPZb7AtMcDUA3QKDZqVkvEn35ED11_1i7vVpc.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\n(function(i,s,o,g,r,a,m){i[\u0022GoogleAnalyticsObject\u0022]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,\u0022script\u0022,\u0022\/\/www.google-analytics.com\/analytics.js\u0022,\u0022ga\u0022);ga(\u0022create\u0022, \u0022UA-15605596-27\u0022, {\u0022cookieDomain\u0022:\u0022auto\u0022});ga(\u0022set\u0022, \u0022page\u0022, location.pathname + location.search + location.hash);ga(\u0022send\u0022, \u0022pageview\u0022);ga(\u0027create\u0027, \u0027UA-189672-26\u0027, \u0027auto\u0027, {\u0027name\u0027: \u0027hwTracker\u0027});\r\nga(\u0027hwTracker.send\u0027, \u0027pageview\u0027);\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022spmdc;11\\\/1\\\/26\u0022},{\u0022requested\u0022:\u0022long\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022spmdc;11\\\/1\\\/26\u0022}],\u0022ac\u0022:{\u0022spmdc;11\\\/1\\\/26\u0022:{\u0022access\u0022:{\u0022reprint\u0022:true,\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022spmdc;11\\\/1\\\/26\u0022,\u0022atom_uri\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022spmdc\u0022}}},\u0022googleanalytics\u0022:{\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackUrlFragments\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/jquery.cluetip.js\u0022:1,\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/lib\\\/jquery.hoverIntent.js\u0022:1,\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/lib\\\/jquery.bgiframe.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u00220\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/cdn\/css\/http\/css_Xg7z6oCTVgud_Q0huYz9x9iiD5H_2YPSJ5z2ZViSWdY.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-sageoa-tab-art\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 id=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2\u003ESummary\u003C\/h2\u003E\n            \u003Cp id=\u0022p-1\u0022\u003EThe following is a summary of presentations from a session that focused on potential improvements in imaging in the design of clinical trials in stroke.\u003C\/p\u003E\n         \u003C\/div\u003E\u003Cul class=\u0022kwd-group\u0022\u003E\u003Cli class=\u0022kwd\u0022\u003ENeurology\u003C\/li\u003E\u003Cli class=\u0022kwd\u0022\u003ENeuroimaging\u003C\/li\u003E\u003Cli class=\u0022kwd\u0022\u003ENeuroimaging Clinical Trials\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-2\u0022\u003EThe following is a summary of presentations from a session that focused on potential improvements in imaging in the design of clinical trials in stroke.\u003C\/p\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-1\u0022\u003E\n         \u003Ch2 class=\u0022\u0022\u003EPatient Selection With PWI\/DWI\u003C\/h2\u003E\n         \u003Cp id=\u0022p-3\u0022\u003EPerfusion- and diffusion-weighted MRI (PWI\/DWI) are imaging technologies that are used increasingly in acute stroke intervention trials to differentiate salvageable from irreversibly injured tissue. Gregory W. Albers, MD, Stanford University Medical Center, Palo Alto, California, and winner of the 2011 Sherman Award, discussed using PWI\/DWI for patient selection in acute stroke reperfusion trials beyond the 3-hour window. The key to the selection process is enrolling patients who are most likely to benefit from reperfusion and unlikely to be harmed. These patients have small, irreversibly injured cores, and large regions with salvageable critical hypoperfusion. Although access to urgent MRI scanning is challenging compared with computed tomography (CT), it is more accurate for identifying the volume and location of the irreversibly injured infarct core, a critical factor in patient selection.\u003C\/p\u003E\n         \u003Cp id=\u0022p-4\u0022\u003EThe use of DWI to define irreversibly damaged infarct core has been challenged by data that suggest the potential for partial reversal of early DWI lesions; however, recent data from the EPITHET and DEFUSE studies demonstrate that true DWI lesion reversal is uncommon in ischemic stroke patients and that when reversal does occur, the volume is very small [Chemmanam T et al. \u003Cem\u003ENeurology\u003C\/em\u003E 2010]. In addition, although transient reversal of DWI lesions following early reperfusion is common, animal studies indicate that transient reversal is associated with widespread neuronal necrosis [Li F et al. \u003Cem\u003EStroke\u003C\/em\u003E 2000]. Recent studies have confirmed the importance of establishing the size of the early ischemic core; patients who present with a large volume of irreversibly injured tissue (\u0026gt;70\u2013100 cc) do not respond favorably to reperfusion therapy [Albers et al. \u003Cem\u003EAn Neurol\u003C\/em\u003E 2006; Yoo AJ et al. \u003Cem\u003EStroke\u003C\/em\u003E 2009].\u003C\/p\u003E\n         \u003Cp id=\u0022p-5\u0022\u003ERecent data, including a study in which PET scans were performed shortly after PWI scans in acute stroke patients, demonstrate that PWI, using a threshold of Tmax \u0026gt;5.5, can identify penumbral tissue with high sensitivity and specificity [Zaro-Weber O et al. \u003Cem\u003EStroke\u003C\/em\u003E 2010].\u003C\/p\u003E\n         \u003Cp id=\u0022p-6\u0022\u003EDr. Albers concluded that accurate identification of core and penumbra is the fundamental challenge to patient selection for extended window clinical trials. \u201cMR can deliver on both of these critical issues, and we should do more to increase our access to acute MRI scans.\u201d\u003C\/p\u003E\n      \u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\n         \u003Ch2 class=\u0022\u0022\u003EUsing Dynamic CT to Assess Perfusion\u003C\/h2\u003E\n         \u003Cp id=\u0022p-7\u0022\u003EDynamic CT perfusion imaging reliably detects tissue that is at risk in cases of acute stroke and is a feasible method for any clinic with a third-generation CT scanner (16-slice or greater). Mark Parsons, MD, PhD, University of Newcastle, New South Wales, Australia, discussed the advantages of using CT perfusion in acute stroke intervention trials.\u003C\/p\u003E\n         \u003Cp id=\u0022p-8\u0022\u003EAdvanced imaging tools are crucial to rescuing salvageable tissue, the \u201choly grail\u201d of acute stroke treatment and future interventional trials. Rapidity of access to MRI is a significant issue, as screening for safety in hyperacute situations can lead to delays, and in some countries, MRI is often monopolized for less urgent outpatient indications.\u003C\/p\u003E\n         \u003Cp id=\u0022p-9\u0022\u003EPerfusion computed tomography (PCT) shows promise in acute stroke assessment. PCT is readily accessible in most clinical centers. Maps of time to peak (TTP), Tmax, cerebral blood volume (CBV), and cerebral blood flow (CBF) can be calculated from the dynamically enhanced scans. CBF maps are excellent predictors of the extent of infarct core [Mayer TE et al. \u003Cem\u003EAm J Neuroradiol\u003C\/em\u003E 2000; Bivard et al. \u003Cem\u003ECerebrovascular Diseases\u003C\/em\u003E 2011].\u003C\/p\u003E\n         \u003Cp id=\u0022p-10\u0022\u003ENoncontrast CT and CT with angiography source images underestimate the baseline infarct core size relative to CTP. In patients who have CTP within 6 hours of stroke, assessment of collateral status using combined CTA and CTP was able to identify core infarct regions, predict the fate of penumbral tissue, and increase the chance of more favorable functional outcomes (modified Rankin Scale score 0\u20132) [Miteff F et al. \u003Cem\u003EBrain\u003C\/em\u003E 2009].\u003C\/p\u003E\n         \u003Cp id=\u0022p-11\u0022\u003EIn conclusion, Prof. Parsons noted, perfusion CT is a good tool for assessing core and penumbra tissue regions and is crucial for future acute stroke interventional trials.\u003C\/p\u003E\n      \u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-3\u0022\u003E\n         \u003Ch2 class=\u0022\u0022\u003EThrombus Detection Using CTA\u003C\/h2\u003E\n         \u003Cp id=\u0022p-12\u0022\u003ETrials, such as European Cooperative Acute Stroke Study (ECASS) and National Institute of Neurological Disorders and Stroke (NINDS II), have shown only a 7% effect size for IV thrombolytics in the treatment of acute ischemic stroke. R\u00fcdiger Von Kummer, MD, PhD, Dresden University Stroke Center, Dresden, Germany, discussed why the majority of patients fail to benefit from IV tPA treatment and how that might be changed.\u003C\/p\u003E\n         \u003Cp id=\u0022p-13\u0022\u003EThe primary reasons for lack of benefit from tPA in some patients are recanalization\/reperfusion failures (eg, not achieving recanalization\/reperfusion, achieving recanalization but only partial reperfusion) and reocclusion in addition to patients with spontaneous reperfusion at admission. Some of the more important conditions that might influence arterial patency include tandem arterial obstruction internal carotid artery\/middle cerebral artery (MCA) and having large thrombi or tight atherosclerotic stenosis. The relative resistance to thrombolysis in tandem lesions varies, depending on the location of the MCA clot, an outcome that may be improved with more informed patient selection [Rubiera M et al. \u003Cem\u003EStroke\u003C\/em\u003E 2006]. In a study of proximal vessel occlusions, baseline CTA identified those patients who were likely to have a low rate of recanalization following IV tPA [Bhatia R et al. \u003Cem\u003EStroke\u003C\/em\u003E 2010]. It also might be possible to quantify the extent of vascular obliteration more accurately with thin-slice non-enhanced CT reconstructions [Riedel CH et al. \u003Cem\u003EStroke\u003C\/em\u003E 2010]. Further early arterial reocclusion on transcranial Doppler is highly predictive of clinical deterioration and poor long-term outcome [Saqqur M et al. \u003Cem\u003EStroke\u003C\/em\u003E 2007].\u003C\/p\u003E\n         \u003Cp id=\u0022p-14\u0022\u003EProf. von Kummer concluded that \u201cassessment of arterial obstruction is mandatory before and after treatment in order to identify patients not likely to benefit from IV rtPA.\u201d\u003C\/p\u003E\n      \u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-4\u0022\u003E\n         \u003Ch2 class=\u0022\u0022\u003EA Simplified Vascular Imaging Paradigm\u003C\/h2\u003E\n         \u003Cp id=\u0022p-15\u0022\u003E\u201cThe problem we face in stroke is we have had too many failed pivotal acute stroke trials,\u201d said Andrew M. Demchuk, MD, University of Calgary, Calgary, Alberta, Canada. \u201cThe heterogeneity and time-dependent nature of stroke have greatly limited our success in advancing stroke treatments.\u201d Prof. Demchuk suggested better patient selection using advanced neurovascular imaging techniques, using a combination of systemic thrombolysis treatments, and earlier, more frequent, and more complete recanalization as solutions.\u003C\/p\u003E\n         \u003Cp id=\u0022p-16\u0022\u003EPatients with a favorable baseline CT scan appearance are the most likely to benefit from IV intra-arterial therapy [Hill MD et al. \u003Cem\u003EAm J Neuroradiol\u003C\/em\u003E 2006]. There is also evidence that good clinical outcome following angiographically successful reperfusion is significantly time-dependent. At later times, angiographic reperfusion may be associated with a poor risk-benefit ratio in unselected patients [Khatri P et al. \u003Cem\u003ENeurology\u003C\/em\u003E 2009]. Overall, patients benefit the most with early recanalization and a favorable baseline CT scan (ASPECTS score \u0026gt;7; \u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E) [Goyal M et al. \u003Cem\u003EStroke\u003C\/em\u003E 2011]. CT-angiogram has additional information regarding extent of thrombus burden and collateral flow, which are key determinants of whether an artery will successfully recanalize and whether a brain that is at risk will go on to infarction. A simple noncontrast CT and CTA approach requires the least amount of time yet provides advanced imaging information for the clinician, using up far fewer of the 1.9 million neurons that are lost with each minute of a stroke.\u003C\/p\u003E\n         \u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/content\/spmdc\/11\/1\/26\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022NCCT ASPECTS and Time to Recanalization.\u0022 class=\u0022fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1210664243\u0022 data-figure-caption=\u0022NCCT ASPECTS and Time to Recanalization.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cimg class=\u0022fragment-image\u0022 alt=\u0022Figure 1.\u0022 src=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/content\/spmdc\/11\/1\/26\/F1.medium.gif\u0022\/\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u00220 first\u0022\u003E\u003Ca href=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/content\/spmdc\/11\/1\/26\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u00221\u0022\u003E\u003Ca href=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/content\/spmdc\/11\/1\/26\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u00222 last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/12236\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption attrib\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1.\u003C\/span\u003E \n               \u003Cp id=\u0022p-17\u0022 class=\u0022first-child\u0022\u003ENCCT ASPECTS and Time to Recanalization.\u003C\/p\u003E\n            \u003Cq class=\u0022attrib\u0022 id=\u0022attrib-1\u0022\u003EReproduced with permission from A. Demchuk, MD.\u003C\/q\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\n         \u003Cp id=\u0022p-18\u0022\u003E\u201cTime is brain,\u201d Prof. Demchuk reminded the audience.\u003C\/p\u003E\n      \u003C\/div\u003E\u003Cul class=\u0022copyright-statement\u0022\u003E\u003Cli class=\u0022fn\u0022 id=\u0022copyright-statement-1\u0022\u003E\u00a9 2011 MD Conference Express\u003C\/li\u003E\u003C\/ul\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan id=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Ca href=\u0022http:\/\/mdc.sagepub.com\/content\/11\/1\/26.abstract\u0022 class=\u0022hw-link hw-link-article-abstract\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView Summary\u003C\/a\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js?nzn4sd\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js?nzn4sd\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}